Olema Oncology to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference Olema Oncology to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference SAN FRANCISCO, Dec. 17, 2020 — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” NASDAQ: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that Sean P. Bohen, M.D., Ph.D., president and chief executive officer, will present at the 39 th Annual J.P. Morgan Virtual Healthcare Conference on Mon...